• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌特异性膜抗原 PET 的研究进展。

Advances in prostate-specific membrane antigen PET of prostate cancer.

机构信息

Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Aarhus, Denmark.

Chief, Molecular Imaging Program, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, Maryland, USA.

出版信息

Curr Opin Oncol. 2018 May;30(3):189-196. doi: 10.1097/CCO.0000000000000439.

DOI:10.1097/CCO.0000000000000439
PMID:29465429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6003670/
Abstract

PURPOSE OF REVIEW

In recent years, a large number of reports have been published on prostate-specific membrane antigen (PSMA)/PET in prostate cancer (PCa). This review highlights advances in PSMA PET in PCa during the past year.

RECENT FINDINGS

PSMA PET/computed tomography (CT) is useful in detection of biochemical recurrence, especially at low prostate-specific antigen (PSA) values. The detection rate of PSMA PET is influenced by PSA level. For primary PCa, PSMA PET/CT shows promise for tumour localization in the prostate, especially in combination with multiparametric MRI (mpMRI). For primary staging, PSMA PET/CT can be used in intermediate and high-risk PCa. Intraoperative PSMA radioligand guidance seems promising for detection of malignant lymph nodes. While the use of PSMA PET/MRI in primary localized disease is limited to high and intermediate-risk patients and localized staging, in the recurrence setting, PET/MRI can be particularly helpful when the lesions are subtle. PSMA PET/CT is superior to choline PET/CT and other conventional imaging modalities.

SUMMARY

Molecular imaging with PSMA PET continues to pave the way for personalized medicine in PCa.However, large prospective clinical studies are still needed to fully evaluate the role of PSMA PET/CT and PET/MRI in the clinical workflow of PCa.

摘要

目的综述

近年来,大量关于前列腺特异性膜抗原(PSMA)/PET 在前列腺癌(PCa)中的报告发表。本文重点介绍了过去一年中 PSMA PET 在 PCa 中的研究进展。

最近的发现

PSMA PET/计算机断层扫描(CT)有助于检测生化复发,尤其是在前列腺特异性抗原(PSA)值较低时。PSMA PET 的检出率受 PSA 水平的影响。对于原发性 PCa,PSMA PET/CT 显示出在前列腺中定位肿瘤的潜力,特别是与多参数 MRI(mpMRI)结合时。对于原发分期,PSMA PET/CT 可用于中高危 PCa。PSMA 放射性配体引导的术中检测恶性淋巴结似乎很有前景。虽然 PSMA PET/MRI 在原发性局限性疾病中的应用仅限于高危和中危患者以及局限性分期,但在复发情况下,当病变较细微时,PET/MRI 可能特别有帮助。PSMA PET/CT 优于胆碱 PET/CT 和其他常规成像方式。

总结

PSMA PET 的分子成像继续为 PCa 的个体化医学铺平道路。然而,仍需要进行大型前瞻性临床研究,以充分评估 PSMA PET/CT 和 PET/MRI 在 PCa 临床工作流程中的作用。

相似文献

1
Advances in prostate-specific membrane antigen PET of prostate cancer.前列腺癌特异性膜抗原 PET 的研究进展。
Curr Opin Oncol. 2018 May;30(3):189-196. doi: 10.1097/CCO.0000000000000439.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL).氟-18 标记的前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描或磁共振成像用于诊断和定位前列腺癌。一项前瞻性单臂配对比较(PEDAL)。
Eur Urol Oncol. 2024 Oct;7(5):1015-1023. doi: 10.1016/j.euo.2024.01.002. Epub 2024 Jan 27.
4
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
5
Comparison of Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.基于与组织病理学逐片比较,比较镓-羟基苄基乙二胺-N,N'-二乙酸-环糊精前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描(Ga-HBED-CC PSMA-PET/CT)和多参数磁共振成像(MRI)在原发性前列腺癌患者中检测大体肿瘤体积的情况。
Theranostics. 2017 Jan 1;7(1):228-237. doi: 10.7150/thno.16638. eCollection 2017.
6
A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.一项前瞻性随机多中心研究,评估镓-68 前列腺特异性膜抗原(PSMA)PET/CT 成像在根治性手术或放疗前对高危前列腺癌分期的影响(proPSMA 研究):临床试验方案。
BJU Int. 2018 Nov;122(5):783-793. doi: 10.1111/bju.14374. Epub 2018 Jun 3.
7
PSMA PET and Radionuclide Therapy in Prostate Cancer.前列腺癌中的前列腺特异性膜抗原正电子发射断层扫描与放射性核素治疗
Semin Nucl Med. 2016 Nov;46(6):522-535. doi: 10.1053/j.semnuclmed.2016.07.006. Epub 2016 Sep 3.
8
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.用于复发性前列腺癌挽救性淋巴结清扫术前的Ga-68-HBED-CC-PSMA配体-PET/CT的诊断准确性
Theranostics. 2017 Apr 10;7(6):1770-1780. doi: 10.7150/thno.18421. eCollection 2017.
9
Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer.前列腺特异性膜抗原 PET/计算机断层扫描在前列腺癌分期中的应用。
Curr Opin Urol. 2020 Sep;30(5):628-634. doi: 10.1097/MOU.0000000000000799.
10
Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.新型前列腺癌正电子发射断层扫描/计算机断层扫描显像剂 GRPR 拮抗剂 BAY86-7548 的前瞻性研究。
Eur Urol Oncol. 2019 Mar;2(2):166-173. doi: 10.1016/j.euo.2018.08.011. Epub 2018 Sep 22.

引用本文的文献

1
Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents.革新前列腺癌检测:已获批的PSMA-PET显像剂的作用
Pharmaceuticals (Basel). 2025 Jun 17;18(6):906. doi: 10.3390/ph18060906.
2
Fully Automated Production of ((()-1-Carboxy-5-(6-([F]fluoro)-2-methoxynicotinamido)pentyl)carbamoyl)-l-glutamic Acid ([F]JK-PSMA-7).((()-1-羧基-5-(6-([F]氟)-2-甲氧基烟酰胺基)戊基)氨基甲酰基)-L-谷氨酸([F]JK-PSMA-7)的全自动生产
Pharmaceuticals (Basel). 2025 Jan 17;18(1):119. doi: 10.3390/ph18010119.
3
High Detection Rates for Prostate-specific Membrane Antigen-avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography.在扩展轴向视野正电子发射断层扫描/计算机断层扫描上,低前列腺特异性抗原水平下前列腺特异性膜抗原亲和性前列腺癌复发的高检出率
Eur Urol Open Sci. 2024 Dec 7;71:49-56. doi: 10.1016/j.euros.2024.11.008. eCollection 2025 Jan.
4
Potential application of [F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma.[F]AlF-PSMA-11正电子发射断层显像/计算机断层扫描(PET/CT)在放射性碘难治性甲状腺癌中的潜在应用
EJNMMI Res. 2024 Sep 12;14(1):82. doi: 10.1186/s13550-024-01148-9.
5
Novel Multiparametric Magnetic Resonance Imaging-Based Deep Learning and Clinical Parameter Integration for the Prediction of Long-Term Biochemical Recurrence-Free Survival in Prostate Cancer after Radical Prostatectomy.基于新型多参数磁共振成像的深度学习与临床参数整合用于预测前列腺癌根治术后长期无生化复发生存情况
Cancers (Basel). 2023 Jun 29;15(13):3416. doi: 10.3390/cancers15133416.
6
Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy.99mTc-HYNIC-PSMA SPECT/CT对前列腺癌根治术后生化复发前列腺癌的诊断性能
Front Oncol. 2022 Dec 7;12:1072437. doi: 10.3389/fonc.2022.1072437. eCollection 2022.
7
Tumor buster - where will the CAR-T cell therapy 'missile' go?肿瘤克星——CAR-T 细胞疗法的“导弹”将飞向何方?
Mol Cancer. 2022 Oct 19;21(1):201. doi: 10.1186/s12943-022-01669-8.
8
Comparison of Multiparametric Magnetic Resonance Imaging with Prostate-Specific Membrane Antigen Positron-Emission Tomography Imaging in Primary Prostate Cancer Diagnosis: A Systematic Review and Meta-Analysis.多参数磁共振成像与前列腺特异性膜抗原正电子发射断层扫描成像在原发性前列腺癌诊断中的比较:一项系统评价和荟萃分析
Cancers (Basel). 2022 Jul 19;14(14):3497. doi: 10.3390/cancers14143497.
9
Prostate-specific membrane antigen positron emission tomography compared to multiparametric MRI for prostate cancer diagnosis: a protocol for a systematic review and meta-analysis.前列腺特异性膜抗原正电子发射断层扫描与多参数 MRI 用于前列腺癌诊断的比较:系统评价和荟萃分析方案。
BMJ Open. 2021 Dec 10;11(12):e052277. doi: 10.1136/bmjopen-2021-052277.
10
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [Ga]Ga-PSMA-11 PET/MRI.基于[Ga]Ga-PSMA-11 PET/MRI 的监督机器学习可实现原发性前列腺癌的无创性病变特征分析。
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1795-1805. doi: 10.1007/s00259-020-05140-y. Epub 2020 Dec 19.

本文引用的文献

1
Preliminary results on response assessment using Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy.使用 Ga-HBED-CC-PSMA PET/CT 评估转移性前列腺癌患者接受多西他赛化疗后反应的初步结果。
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):602-612. doi: 10.1007/s00259-017-3887-x. Epub 2017 Nov 28.
2
Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.前列腺癌寡转移灶:低分割 IGRT 后 PSMA-PET-CT 随访中的代谢反应。
Strahlenther Onkol. 2018 Apr;194(4):318-324. doi: 10.1007/s00066-017-1239-1. Epub 2017 Nov 27.
3
Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges.前列腺癌的功能及靶向淋巴结成像:现状与未来挑战
Radiology. 2017 Dec;285(3):728-743. doi: 10.1148/radiol.2017161517.
4
Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.在 PSA 水平低于 1.0ng/ml 的 270 例患者中,Ga-PSMA-11 PET/CT 对前列腺癌根治术后生化复发的定位:对挽救性放疗计划的影响。
J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9.
5
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT.前列腺癌分子影像学标准化评估(PROMISE):用于解释 PSMA 配体 PET/CT 的 miTNM 分类建议。
J Nucl Med. 2018 Mar;59(3):469-478. doi: 10.2967/jnumed.117.198119. Epub 2017 Nov 9.
6
Comparison of Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer.镓-PSMA-11 PET-CT 与 mpMRI 用于中高危前列腺癌患者术前淋巴结分期的比较。
J Transl Med. 2017 Nov 7;15(1):230. doi: 10.1186/s12967-017-1333-2.
7
Gallium-Prostate-Specific Membrane Antigen PET/Computed Tomography for Primary and Secondary Staging in Prostate Cancer.镓-前列腺特异性膜抗原PET/计算机断层扫描用于前列腺癌的原发和继发分期
Urol Clin North Am. 2017 Nov;44(4):557-563. doi: 10.1016/j.ucl.2017.07.004.
8
Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans.Ga-PSMA-11 PET/CT 在前列腺癌的初步分期中的应用:南非黑人和白人之间差异的初步结果。
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):226-234. doi: 10.1007/s00259-017-3852-8. Epub 2017 Nov 4.
9
Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature.镓-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描用于检测前列腺癌骨转移:已发表文献的系统评价
Clin Physiol Funct Imaging. 2017 Oct 29. doi: 10.1111/cpf.12480.
10
Prostate-specific membrane antigen-guided salvage lymph node dissection in recurrent prostate cancer: a novel technology to detect lymph node metastases.前列腺特异性膜抗原引导的复发性前列腺癌挽救性淋巴结清扫术:一种检测淋巴结转移的新技术。
Curr Opin Urol. 2018 Mar;28(2):191-196. doi: 10.1097/MOU.0000000000000458.